LON:SBS Source BioScience (SBS) Share Price, News & Analysis → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free SBS Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume458,233 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Source BioScience alerts: Email Address Ad The TradingPubAt first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… About Source BioScience Stock (LON:SBS)Source BioScience plc is a provider of laboratory services and products to the healthcare and clinical, life and applied sciences and biopharmaceutical industries. The Company operates through two segments: Laboratory Services and Products. The Company's Laboratory Services segment consists of the laboratory and analytical testing activities of the Group including diagnostic testing for cancer and infectious disease; deoxyribonucleic acid (DNA) sequencing and contract research activities; stability and cryostorage in addition to analytical services, and stability testing. The Company's Products segment consists of portfolio of Clinical Products, including serology products for blood and tissue banking and liquid-based cytology products for cervical cancer screening, in addition to the portfolio of Life Science Research Reagents, including complementary DNA (cDNA) clones and other biomolecular tools, and controlled environment storage equipment and related servicing and validation.Read More Ad The TradingPubAt first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… SBS Stock News HeadlinesApril 22, 2024 | tmcnet.comArizona Bioscience Growth Continues, Sets Record HighsMarch 28, 2024 | msn.comCellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call TranscriptApril 25, 2024 | The TradingPub (Ad)At first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”February 3, 2024 | msn.comCellectar Biosciences Announces Recent Share Issuance UpdateJanuary 12, 2024 | msn.comResearchers find Boswellia, an extract of frankincense, shows anti-cancer activity in small trialDecember 21, 2023 | markets.businessinsider.comBedrock Bioscience Announces Groundbreaking Medical Study Published in Prestigious JournalNovember 17, 2023 | marketwatch.comTwist Bioscience Shares Climb on Strong 4Q, Upbeat OutlookNovember 9, 2023 | marketwatch.comNeurocrine Biosciences Shares Fall After Two Studies Fail to Achieve Desired ResultsApril 25, 2024 | The TradingPub (Ad)At first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”September 25, 2023 | benzinga.comHuman Microbiome Market size worth USD 1,689.5 Million, Globally, by 2027 at 21.8% CAGR: Verified Market Research®September 1, 2023 | npr.orgTPR: The SourceAugust 1, 2023 | finanznachrichten.deTwist Bioscience DNA-Based Tools Now Available in Ireland From MyBioJuly 21, 2023 | benzinga.comUS FDA Grants Orphan Drug Designation of SN Bioscience's Nano Anti-Cancer Drug 'SNB-101' for Small Cell Lung CancerJuly 2, 2023 | msn.comWest End Labs signs first tenant in Graviton Bioscience for new 400K-square-foot life sciences buildingJune 19, 2023 | markets.businessinsider.comSK bioscience COVID-19 Vaccine Granted Emergency Use Listing by the World Health OrganizationMay 17, 2023 | marketwatch.comStyrene-Butadiene-Styrene (SBS) Block Copolymer Market 2023: Insights and Strategies | 2031May 13, 2023 | msn.comXenetic Biosciences announces reverse stock split of common stockMay 10, 2023 | marketwatch.comSequencing By Synthesis(Sbs) Market Analysis [2023-2030] Understanding the Latest Market TrendsMay 9, 2023 | marketwatch.comSolid Bleached Sulfate (SBS) Board Market in 2030: Insights, Strategies, and ProjectionsApril 18, 2023 | techrepublic.com6 best open-source kanban boards for managing projects in 2023March 14, 2023 | lse.co.ukSource BioScience Agrees GBP62.9 Million Takeover DealFebruary 23, 2023 | benzinga.comOn the rise in 2023: Six Arizona bioscience startupsFebruary 22, 2023 | uk.finance.yahoo.comClinical Oncology Next Generation Sequencing Global Market Report 2023February 3, 2023 | marketwatch.comTwist Bioscience Shares Slide 19%; 2Q Revenue Guidance Below EstimatesJanuary 28, 2023 | benzinga.comBioinformatics Services Market is expected to grow from USD 2.8 billion in 2022 to USD 8.7 billion by 2030 : GreyViewsJanuary 12, 2023 | marketwatch.comStocks to Watch: Disney, Yield10 Bioscience, KB HomeDecember 27, 2022 | technews.tmcnet.comCatalyst Biosciences Completes First Steps in Reverse Merger PlanSee More Headlines Receive SBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Source BioScience and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryN/A Current SymbolLON:SBS CUSIPN/A CIKN/A Webwww.sabesp.com.br Phone+44-115-9739012FaxN/AEmployees2,020Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key Competitors(BAV.L)LON:BAV(GFIR.L)LON:GFIR(HHVT.L)LON:HHVT(JDT.L)LON:JDT(JUB.L)LON:JUBView All Competitors SBS Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Source BioScience own? Based on aggregate information from My MarketBeat watchlists, some companies that other Source BioScience investors own include Anglo American (AAL), Hastings Group Holdings plc (HSTG.L) (HSTG), Renishaw (RSW), Spirent Communications (SPT), Rotork (ROR), Hiscox (HSX), Anglo American (NGLOY), SEB (SKP), discoverIE Group (DSCV) and DiamondCorp (DCP). How do I buy shares of Source BioScience? Shares of SBS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:SBS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Source BioScience plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
